Litcius/Paper detail

Bone-modifying Agents (BMAs) in Breast Cancer

Charles L. Shapiro

2021Clinical Breast Cancer24 citationsDOI

Topics & Concepts

MedicineDenosumabZoledronic acidBreast cancerOsteoporosisVitamin D and neurologyAromataseInternal medicineBone mineralOncologyCancerSurgeryUrologyBone health and treatmentsRadiopharmaceutical Chemistry and ApplicationsBone and Joint Diseases
Bone-modifying Agents (BMAs) in Breast Cancer | Litcius